$VTR
Ventas, Inc. Stock $vtr

$vtr Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000074026020000163 Filed on November 06, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$921.2M	$918.9M	$983.2M
YoY Change	-7.51%	-6.53%	4.98%
Cost Of Revenue	$463.4M	$495.5M	$462.1M
YoY Change	-3.64%	7.23%	7.77%
Gross Profit	$457.8M	$423.4M	$521.0M
YoY Change	-11.14%	-18.73%	2.62%
Gross Profit Margin	49.7%	46.07%	52.99%
Selling, General & Admin	$23.40M	$34.20M	$40.50M
YoY Change	-43.75%	-15.56%	2.02%
% of Gross Profit	5.11%	8.08%	7.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$262.0M	$249.4M	$234.6M
YoY Change	-24.91%	6.31%	7.32%
% of Gross Profit	57.23%	58.9%	45.03%
Operating Expenses	$261.0M	$275.6M	$266.1M
YoY Change	-6.62%	3.57%	3.02%
Operating Profit	$196.8M	$147.8M	$254.9M
YoY Change	-16.5%	-42.02%	2.21%
Interest Expense	-$96.50M	$115.5M	$114.0M
YoY Change	-17.17%	1.35%	5.94%
% of Operating Profit	-49.03%	78.15%	44.71%
Other Income/Expense, Net	$20.30M	-$5.681M	-$2.164M
YoY Change	144.58%	162.52%	73.95%
Pretax Income	$111.3M	-$2.945M	$88.90M
YoY Change	718.38%	-103.31%	-7.4%
Income Tax	-$700.0K	-$3.195M	$2.005M
% Of Pretax Income	-0.63%		2.26%
Net Earnings	$112.0M	$13.74M	$86.92M
YoY Change	768.32%	-84.2%	-15.84%
Net Earnings / Revenue	12.15%	1.49%	8.84%
Basic Earnings Per Share	$0.29	$0.03	$0.23
Diluted Earnings Per Share	$0.29	$0.03	$0.23
COMMON SHARES
Basic Shares Outstanding	374.6M shares	373.2M shares	372.4M shares
Diluted Shares Outstanding		376.3M shares	376.6M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$413.0M	$588.0M	$148.0M
YoY Change	289.62%	297.3%	72.09%
Cash & Equivalents	$413.3M	$600.0M	$148.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$413.0M	$588.0M	$148.0M
YoY Change	289.62%	297.3%	72.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.55B	$20.98B	$21.93B
YoY Change	-5.43%	-4.35%	9.54%
Goodwill	$1.052B	$1.051B	$1.050B
YoY Change	0.05%	0.07%
Intangibles
YoY Change
Long-Term Investments	$745.0M	$437.0M	$165.0M
YoY Change	117.84%	164.85%	-48.28%
Other Assets	$58.00M	$56.00M	$65.00M
YoY Change	-67.6%	-13.85%	-25.29%
Total Long-Term Assets	$23.52B	$23.63B	$24.66B
YoY Change	-4.35%	-4.15%	9.52%
TOTAL ASSETS
Total Short-Term Assets	$413.0M	$588.0M	$148.0M
Total Long-Term Assets	$23.52B	$23.63B	$24.66B
Total Assets	$23.93B	$24.22B	$24.80B
YoY Change	-3.09%	-2.35%	9.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.133B	$1.235B	$1.194B
YoY Change	-1.13%	3.43%	5.2%
Accrued Expenses	$321.0M	$345.0M	$334.0M
YoY Change	-11.33%	3.29%	333.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.454B	$1.580B	$1.528B
YoY Change	-3.58%	3.4%	26.07%
LONG-TERM LIABILITIES
Long-Term Debt	$11.90B	$12.05B	$12.05B
YoY Change	-2.17%	-0.04%	15.03%
Other Long-Term Liabilities	$3.000M	$2.000M	$2.000M
YoY Change	-40.0%	0.0%	-86.67%
Total Long-Term Liabilities	$11.90B	$12.05B	$12.06B
YoY Change	-2.19%	-0.04%	14.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.454B	$1.580B	$1.528B
Total Long-Term Liabilities	$11.90B	$12.05B	$12.06B
Total Liabilities	$13.42B	$13.68B	$13.73B
YoY Change	-3.3%	-0.34%	14.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.030B	-$3.973B	-$3.384B
YoY Change	9.85%	17.38%
Common Stock	$14.26B	$14.24B	$14.11B
YoY Change	0.81%	0.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change	-100.0%
Treasury Stock Shares	0.000 shares	33.00K shares
Shareholders Equity	$10.18B	$10.20B	$10.67B
YoY Change
Total Liabilities & Shareholders Equity	$23.93B	$24.22B	$24.80B
YoY Change	-3.09%	-2.35%	9.76%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	$112.0M	$13.74M	$86.92M
YoY Change	768.32%	-84.2%	-15.84%
Depreciation, Depletion And Amortization	$262.0M	$249.4M	$234.6M
YoY Change	-24.91%	6.31%	7.32%
Cash From Operating Activities	$295.8M	$434.4M	$354.3M
YoY Change	-16.51%	22.61%	15.29%
INVESTING ACTIVITIES
Capital Expenditures	-$124.2M	-$170.5M	-$157.0M
YoY Change	-46.23%	8.6%	48.53%
Acquisitions
YoY Change
Other Investing Activities	$91.90M	$9.000M	-$757.1M
YoY Change	36.15%	-101.19%	-1793.74%
Cash From Investing Activities	-$32.30M	-$161.5M	-$914.2M
YoY Change	-80.23%	-82.33%	1398.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-442.3M	-674.5M	630.0M
YoY Change	73.86%	-207.06%	-346.29%
NET CHANGE
Cash From Operating Activities	295.8M	434.4M	354.3M
Cash From Investing Activities	-32.30M	-161.5M	-914.2M
Cash From Financing Activities	-442.3M	-674.5M	630.0M
Net Change In Cash	-178.8M	-401.6M	70.10M
YoY Change	181.57%	-672.9%	-837.89%
FREE CASH FLOW
Cash From Operating Activities	$295.8M	$434.4M	$354.3M
Capital Expenditures	-$124.2M	-$170.5M	-$157.0M
Free Cash Flow	$420.0M	$604.9M	$511.3M
YoY Change	-28.24%	18.31%	23.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000740260
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	374570775	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.25
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.25
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	373940000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	372811000	shares
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	33000	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2000	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-10989
	dei	Entity Registrant Name EntityRegistrantName	Ventas, Inc.
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60654
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	61-1055020
	dei	Entity Address Address Line1 EntityAddressAddressLine1	353 N. Clark Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 3300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
	dei	Entity Address Country EntityAddressCountry	US
	dei	City Area Code CityAreaCode	877
	dei	Local Phone Number LocalPhoneNumber	483-6827
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Trading Symbol TradingSymbol	VTR
	dei	Security12b Title Security12bTitle	Common Stock, $0.25 par value
	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	374570775	shares
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	us-gaap	Land And Land Improvements LandAndLandImprovements	2268583000	USD
CY2019Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	2285648000	USD
CY2020Q3	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	24196730000	USD
CY2019Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	24386051000	USD
CY2020Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	567052000	USD
CY2019Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	461815000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1246312000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1308077000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	386946000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	385225000	USD
CY2020Q3	vtr	Realestateinvestmentsgross Realestateinvestmentsgross	28665623000	USD
CY2019Q4	vtr	Realestateinvestmentsgross Realestateinvestmentsgross	28826816000	USD
CY2020Q3	vtr	Accumulateddepreciationandamortization Accumulateddepreciationandamortization	7687211000	USD
CY2019Q4	vtr	Accumulateddepreciationandamortization Accumulateddepreciationandamortization	7092243000	USD
CY2020Q3	vtr	Netrealestateproperty Netrealestateproperty	20978412000	USD
CY2019Q4	vtr	Netrealestateproperty Netrealestateproperty	21734573000	USD
CY2020Q3	vtr	Secured Notes And Loans Receivable Net SecuredNotesAndLoansReceivableNet	604452000	USD
CY2019Q4	vtr	Secured Notes And Loans Receivable Net SecuredNotesAndLoansReceivableNet	704612000	USD
CY2020Q3	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	162860000	USD
CY2019Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	45022000	USD
CY2020Q3	vtr	Netrealestateinvestments Netrealestateinvestments	21745724000	USD
CY2019Q4	vtr	Netrealestateinvestments Netrealestateinvestments	22484207000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	588343000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	106363000	USD
CY2020Q3	vtr	Escrowdepositsandrestrictedcash Escrowdepositsandrestrictedcash	40147000	USD
CY2019Q4	vtr	Escrowdepositsandrestrictedcash Escrowdepositsandrestrictedcash	39739000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	1050742000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1051161000	USD
CY2020Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	15748000	USD
CY2019Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	85527000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	304000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	47495000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	779475000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	877716000	USD
CY2020Q3	us-gaap	Assets Assets	24220483000	USD
CY2019Q4	us-gaap	Assets Assets	24692208000	USD
CY2020Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	12047919000	USD
CY2019Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	12158773000	USD
CY2020Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	97828000	USD
CY2019Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	111115000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	247255000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	251196000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1234933000	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1145939000	USD
CY2020Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	1987000	USD
CY2019Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	5224000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	53711000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	200831000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	13683633000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	13873078000	USD
CY2020Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	249143000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	273678000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	93467000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	93185000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14142349000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14056453000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-65042000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-34564000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3972647000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3669050000	USD
CY2020Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1275000	USD
CY2019Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	132000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	10196852000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	10445892000	USD
CY2020Q3	us-gaap	Minority Interest MinorityInterest	90855000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	99560000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10287707000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10545452000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24220483000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24692208000	USD
CY2020Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	354512000	USD
CY2019Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	408322000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1126934000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1208388000	USD
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18666000	USD
CY2019Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	30164000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	62203000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	66819000	USD
CY2020Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	572000	USD
CY2019Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	620000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	10109000	USD
CY2020Q3	us-gaap	Revenues Revenues	918940000	USD
CY2019Q3	us-gaap	Revenues Revenues	983155000	USD
	us-gaap	Revenues Revenues	2874192000	USD
	us-gaap	Revenues Revenues	2876746000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	115505000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	113967000	USD
	us-gaap	Interest Expense InterestExpense	355333000	USD
	us-gaap	Interest Expense InterestExpense	334955000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	249366000	USD
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	234603000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	847797000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	696710000	USD
CY2020Q3	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	494985000	USD
CY2019Q3	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	461493000	USD
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	1474558000	USD
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	1327898000	USD
CY2020Q3	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	557000	USD
CY2019Q3	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	627000	USD
	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	1775000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34228000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40530000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106747000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	124369000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7386000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-37434000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7386000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-41861000	USD
CY2020Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11325000	USD
CY2019Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4304000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	26129000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11084000	USD
CY2020Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	4999000	USD
CY2019Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	34654000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3534000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2164000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10624000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9294000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	921885000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	895122000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2865055000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2529358000	USD
CY2020Q3	vtr	Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest	-2945000	USD
CY2019Q3	vtr	Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest	88033000	USD
	vtr	Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest	9137000	USD
	vtr	Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest Incomelossfromcontinuingoperationsbeforeequitymethodinvestmentsrealestatedispositionsincometaxesandnoncontrollinginterest	347388000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	865000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	854000	USD
CY2019Q3	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	854000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-15861000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2621000	USD
CY2020Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	12622000	USD
CY2019Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	36000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	240101000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2005000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-95855000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-57004000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	240101000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	24633000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3195000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	13737000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	86918000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	329232000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	426404000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	13737000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	86918000	USD
	us-gaap	Profit Loss ProfitLoss	329232000	USD
	us-gaap	Profit Loss ProfitLoss	426404000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	986000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1659000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	534000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4831000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12751000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	85259000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	421573000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.88
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.17
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.88
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.16
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2020Q3	us-gaap	Profit Loss ProfitLoss	13737000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	86918000	USD
	us-gaap	Profit Loss ProfitLoss	329232000	USD
	us-gaap	Profit Loss ProfitLoss	426404000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	7907000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-7011000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-4942000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-11770000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	10431000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3162000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-9828000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3734000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1714000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-10013000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-19661000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-32076000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	20052000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20186000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34431000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-40112000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	33789000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	66732000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	294801000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	386292000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3320000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1659000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3419000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4831000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30469000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	65073000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	298220000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	381461000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10399910000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	13737000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	20052000	USD
CY2020Q3	vtr	Noncontrolling Interest Period Increase Decreaseincludingtheimpactto Equity NoncontrollingInterestPeriodIncreaseDecreaseincludingtheimpacttoEquity	7335000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2020Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	166738000	USD
CY2020Q3	vtr	Stock Issued During Period Value Sharebased Payment Arrangements Restricted Stock Awardsand Otherafter Forfeiture StockIssuedDuringPeriodValueSharebasedPaymentArrangementsRestrictedStockAwardsandOtherafterForfeiture	39752000	USD
CY2020Q3	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	-11669000	USD
CY2020Q3	vtr	Adjustments To Additional Paid In Capital Stock Purchase Of Limited Partnership Units AdjustmentsToAdditionalPaidInCapitalStockPurchaseOfLimitedPartnershipUnits	-2000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10287707000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10876362000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	86918000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20186000	USD
CY2019Q3	vtr	Noncontrolling Interest Period Increase Decreaseincludingtheimpactto Equity NoncontrollingInterestPeriodIncreaseDecreaseincludingtheimpacttoEquity	-37059000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10760223000	USD
CY2019Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.7925
CY2019Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	296393000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	76280000	USD
CY2019Q3	vtr	Stock Issued During Period Value Sharebased Payment Arrangements Restricted Stock Awardsand Otherafter Forfeiture StockIssuedDuringPeriodValueSharebasedPaymentArrangementsRestrictedStockAwardsandOtherafterForfeiture	16483000	USD
CY2019Q3	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	-16015000	USD
CY2019Q3	vtr	Adjustments To Additional Paid In Capital Stock Purchase Of Limited Partnership Units AdjustmentsToAdditionalPaidInCapitalStockPurchaseOfLimitedPartnershipUnits	-285000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10545452000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	534000	USD
	us-gaap	Profit Loss ProfitLoss	329232000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34431000	USD
	vtr	Noncontrolling Interest Period Increase Decreaseincludingtheimpactto Equity NoncontrollingInterestPeriodIncreaseDecreaseincludingtheimpacttoEquity	10446000	USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.6925
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	631346000	USD
	vtr	Stock Issued During Period Value Sharebased Payment Arrangements Restricted Stock Awardsand Otherafter Forfeiture StockIssuedDuringPeriodValueSharebasedPaymentArrangementsRestrictedStockAwardsandOtherafterForfeiture	53157000	USD
	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	36353000	USD
	vtr	Adjustments To Additional Paid In Capital Stock Purchase Of Limited Partnership Units AdjustmentsToAdditionalPaidInCapitalStockPurchaseOfLimitedPartnershipUnits	-264000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10287707000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10271594000	USD
	us-gaap	Profit Loss ProfitLoss	426404000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-40112000	USD
	vtr	Noncontrolling Interest Period Increase Decreaseincludingtheimpactto Equity NoncontrollingInterestPeriodIncreaseDecreaseincludingtheimpacttoEquity	-32403000	USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.3775
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	876581000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	942436000	USD
	vtr	Stock Issued During Period Value Sharebased Payment Arrangements Restricted Stock Awardsand Otherafter Forfeiture StockIssuedDuringPeriodValueSharebasedPaymentArrangementsRestrictedStockAwardsandOtherafterForfeiture	54750000	USD
	vtr	Adjustments To Additional Paid In Capital Related To Redeemable Operating Partner Unitholder Interests To Record At Fair Value AdjustmentsToAdditionalPaidInCapitalRelatedToRedeemableOperatingPartnerUnitholderInterestsToRecordAtFairValue	-51024000	USD
	vtr	Adjustments To Additional Paid In Capital Stock Purchase Of Limited Partnership Units AdjustmentsToAdditionalPaidInCapitalStockPurchaseOfLimitedPartnershipUnits	-285000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10760223000	USD
	us-gaap	Profit Loss ProfitLoss	329232000	USD
	us-gaap	Profit Loss ProfitLoss	426404000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	847797000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	696710000	USD
	vtr	Amortizationof Deferred Revenueand Lease Intangibles AmortizationofDeferredRevenueandLeaseIntangibles	-25343000	USD
	vtr	Amortizationof Deferred Revenueand Lease Intangibles AmortizationofDeferredRevenueandLeaseIntangibles	-6484000	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	15211000	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	16910000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	34654000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	17322000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	26670000	USD
	us-gaap	Straight Line Rent StraightLineRent	-107134000	USD
	us-gaap	Straight Line Rent StraightLineRent	25680000	USD
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-7386000	USD
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-41861000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	240101000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	24633000	USD
	vtr	Gains Losseson Real Estate Loan Investments GainsLossesonRealEstateLoanInvestments	167000	USD
	vtr	Gains Losseson Real Estate Loan Investments GainsLossesonRealEstateLoanInvestments	0	USD
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-99702000	USD
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-60249000	USD
	vtr	Income Loss From Equity Method Investments Non Cash Portion IncomeLossFromEquityMethodInvestmentsNonCashPortion	-15869000	USD
	vtr	Income Loss From Equity Method Investments Non Cash Portion IncomeLossFromEquityMethodInvestmentsNonCashPortion	-2621000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2960000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1400000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-15615000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9236000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	68228000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	59366000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-12975000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-15909000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	207749000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	54057000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1154413000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1083548000	USD
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	77625000	USD
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	939805000	USD
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	113147000	USD
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	1257577000	USD
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	682604000	USD
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	77555000	USD
	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	106966000	USD
	us-gaap	Proceeds From Sale And Collection Of Loans Receivable ProceedsFromSaleAndCollectionOfLoansReceivable	1008683000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	309967000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	229845000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	94407000	USD
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	99787000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	151000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	7832000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1711000	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-33000	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-20457000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	186625000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1421879000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-74144000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	278677000	USD
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	-565524000	USD
	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	304508000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	657557000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2206577000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	127528000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2456135000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7564000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	17867000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	36395000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	942250000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	760363000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	861789000	USD
	vtr	Cash Distributionsto Redeemable Op Unitholders CashDistributionstoRedeemableOPUnitholders	5954000	USD
	vtr	Cash Distributionsto Redeemable Op Unitholders CashDistributionstoRedeemableOPUnitholders	6882000	USD
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	575000	USD
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	361000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1138000	USD
	us-gaap	Transfer Of Investments TransferOfInvestments	169484000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	4959000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9666000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	6403000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3518000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34134000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4989000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6601000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-857699000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	415067000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	483339000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	76736000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-951000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	396000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146102000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	131464000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	628490000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208596000	USD
	us-gaap	Transfer Of Investments TransferOfInvestments	1056481000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	1224000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	11123000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	55368000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	907746000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	2707000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	46336000	USD
	vtr	Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed	337000	USD
	vtr	Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed NoncashOrPartNoncashAcquisitionDeferredIncomeTaxLiabilitiesAssumed	0	USD
	vtr	Noncontrollinginterestassumedfromacquisitions Noncontrollinginterestassumedfromacquisitions	20259000	USD
	vtr	Noncontrollinginterestassumedfromacquisitions Noncontrollinginterestassumedfromacquisitions	113522000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1—DESCRIPTION OF BUSINESS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Ventas, Inc. (together with its subsidiaries, unless otherwise indicated or except where the context otherwise requires, “we,” “us” or “our”), an S&P 500 company, is a real estate investment trust (“REIT”) with a highly diversified portfolio of senior housing, research and innovation, and healthcare properties located throughout the United States, Canada and the United Kingdom. As of September 30, 2020, we owned or managed through unconsolidated joint ventures approximately 1,200 properties (including properties classified as held for sale), consisting of senior housing communities, medical office buildings (“MOBs”), research and innovation centers, inpatient rehabilitation facilities (“IRFs”) and long-term acute care facilities (“LTACs”), and health systems. We also had 19 properties under development, including one property that is owned by an unconsolidated real estate entity. Our company was originally founded in 1983 and is headquartered in Chicago, Illinois. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We primarily invest in senior housing, research and innovation, and healthcare properties through acquisitions and lease our properties to unaffiliated tenants or operate them through independent third-party managers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of September 30, 2020, we leased a total of 377 properties (excluding properties within our office operations reportable business segment) to various healthcare operating companies under “triple-net” or “absolute-net” leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures. Our three largest tenants, Brookdale Senior Living Inc. (together with its subsidiaries, “Brookdale Senior Living”), Ardent Health Partners, LLC (together with its subsidiaries, “Ardent”) and Kindred Healthcare, LLC (together with its subsidiaries, “Kindred”) leased from us 121 properties (excluding seven properties managed by Brookdale Senior Living pursuant to long-term management agreements), 11 properties and 32 properties, respectively, as of September 30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of September 30, 2020, pursuant to long-term management agreements, we engaged independent operators, such as Atria Senior Living, Inc. (“Atria”) and Sunrise Senior Living, LLC (together with its subsidiaries, “Sunrise”), to manage 439 senior housing communities for us. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Through our Lillibridge Healthcare Services, Inc. subsidiary and our ownership interest in PMB Real Estate Services LLC, we also provide MOB management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. In addition, from time to time, we make secured and non-mortgage loans and other investments relating to senior housing and healthcare operators or properties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">COVID-19 Update</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The novel coronavirus (“COVID-19”) pandemic and actions taken to prevent its spread continue to affect our business in a number of differing ways. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our senior living operating portfolio, leading indicators in senior housing, including leads, tours and move-ins, showed consistent improvement from July through September, but occupancy continued to decline and operating costs related to COVID-19 remained elevated in the third quarter. Recent COVID-19 clinical trends remain dynamic and create significant uncertainty. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NNN senior housing tenants’ performance has also been affected by COVID-19. While we received substantially all NNN senior housing rent we expected to receive in the third quarter, we have modified certain NNN senior housing leases to reset rent and have provided other modest financial accommodations to certain NNN senior housing tenants who need it as a result of COVID-19. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s NNN healthcare tenants have benefitted from significant government financial support that was deployed early and has partially offset the direct financial impact of the pandemic. Substantially all expected rent was paid by the Company’s NNN healthcare tenants in the third quarter. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our office operations segment delivered steady performance in the third quarter, growing net operating income (“NOI”, which is defined as total revenues, excluding interest and other income, less property-level operating expenses and office building services costs) modestly compared to the second quarter. In the third quarter, we received 99% of contractual rents in the office segment. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government, as well as state and local governments, have implemented or announced programs to provide financial and other support to businesses affected by the COVID-19 pandemic, some of which have benefitted or could benefit our company, tenants, operators, borrowers and managers. In particular, in early September, the Department of Health and Human Services (“HHS”) announced that assisted living communities are eligible to apply for funding under the Phase II General Distribution allocation (“Phase II”) of the Public Health and Social Services Emergency Fund (the “Provider Relief Fund”) established pursuant to the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) and the Paycheck Protection Program and Health Care Enhancement Act (the “PPPHCE Act”). Distributions under Phase II are expected to equal 2% of annual revenues from patient care, and to benefit the assisted living communities in the Company’s senior living operating business, as well as its NNN senior housing tenants. While the guidance from HHS is subject to change, under current guidance, distributions from the Provider Relief Fund are not subject to repayment, provided that the recipient uses the funds first for expenses attributable to COVID-19 and then for lost revenue attributable to COVID-19, and is able to attest to and comply with certain terms and conditions, including not using funds received from the Provider Relief Fund to reimburse expenses or losses that other sources are obligated to reimburse, providing detailed reporting to HHS, maintaining records in accordance with law and submitting to government audit and investigation. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have applied for approximately $35 million in grants under Phase II of the Provider Relief Fund on behalf of the assisted living communities in our senior living operating business. Although we have begun to receive amounts under some of those applications, there can be no assurance that all our applications will be approved or that additional funds will ultimately be received in full or in part. The Company continues to evaluate the terms, conditions and permitted uses associated with the grants, including the requirements and restrictions imposed by HHS, and is in the process of determining what portions of these grants the Company will be able to retain and use. Any funds that are ultimately received and retained by us are not expected to fully offset the losses incurred in the Company’s senior living operating portfolio that are attributable to COVID-19. We believe that substantially all our NNN senior housing tenants have also applied for funding under Phase II to partially mitigate the losses they have incurred as a direct result of COVID-19. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HHS recently announced a new $20 billion Phase III General Distribution allocation (“Phase III”) of the Provider Relief Fund, which will be made available to all healthcare providers, including assisted living communities, who have previously received distributions from the Provider Relief Fund. Phase III is expected to be distributed (i) first, to ensure that eligible providers have received funding equal to at least 2% of their annual patient care revenues and (ii) second, to provide an additional payment that considers providers’ overall financial losses caused by the COVID-19 pandemic. The actual amount paid to providers will depend in part on how many providers apply in Phase III and will be determined after all applications have been received. While we have applied for funding under Phase III on behalf of the assisted living communities in our senior living operating business, there can be no assurance that we will receive funding under Phase III or the amount of any such funding. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HHS and the Department of Defense (the “DOD”) have announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to residents of long-term care facilities nationwide (including assisted living and independent living communities) with no out-of-pocket costs to residents or the communities where they live. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HHS and DOD also announced a program for the delivery of COVID-19 rapid point-of-care diagnostic tests to certain qualified assisted living facilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we expect both of these programs to benefit our senior living operating portfolio, as well as our NNN senior housing tenants, there can be no assurance these programs will ultimately be implemented, will be implemented on the same terms as have been currently announced or will continue once implemented.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the start of the COVID-19 pandemic, we have taken precautionary steps to increase liquidity and preserve financial flexibility in light of the resulting uncertainty. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Management’s Discussion and Analysis of Financial Condition and Results of Operations; Liquidity and Capital Resources; Recent Capital Conservation Actions.” As of November 5, 2020, we had approximately $3.2 billion in liquidity, including availability under our revolving credit facility and cash and cash equivalents on hand, with no borrowings outstanding under our commercial paper program and negligible near-term debt maturing.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trajectory and future impact of the COVID-19 pandemic remains highly uncertain. COVID-19 clinical trends have worsened in recent weeks; and multiple jurisdictions have recently imposed or are re-imposing heightened preventative measures. The extent of the COVID-19 pandemic’s continuing and ultimate effect on our operational and financial performance will depend on the clinical experience, which may differ considerably across regions and fluctuate over time, and on other future developments, including the ultimate duration, spread and intensity of the outbreak; the availability and effective distribution of testing and, eventually, a vaccine; the extent to which governments across the country impose or re-impose preventative restrictions and the extent and duration of any rollback of those restrictions; and the availability of government financial support to our business, tenants and operators. Due to these uncertainties, we are not able at this time </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to estimate the impact of the COVID-19 pandemic on our business, results of operations, financial condition and cash flows, either in the short or long-term, but it could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have not identified the COVID-19 pandemic, on its own, as a “triggering event” for purposes of evaluating impairment of real estate assets, goodwill and other intangibles, investments in unconsolidated entities and financial instruments. However, as of September 30, 2020, we considered the effect of the pandemic on certain of our assets (described below) and our ability to recover the respective carrying values of these assets. We applied our considerations to existing critical accounting policies that require us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities. We based our estimates on our experience and on assumptions we believe to be reasonable under the circumstances. As a result, we have recognized the following charges for the three and nine months ended September 30, 2020:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Adjustment to rental income:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of September 30, 2020, we concluded that it is probable we would not collect substantially all rents from certain tenants, primarily within our triple-net leased properties segment. As a result, we recognized adjustments to rental income of $20.3 million and $74.5 million for the three and nine months ended September 30, 2020. Rental payments from these tenants will be recognized in rental income when received.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Impairment of real estate assets:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of September 30, 2020, we compared our estimate of undiscounted cash flows, including a hypothetical terminal value, for certain real estate assets to the assets' respective carrying values. No impairment charges were recognized for the quarter ended September 30, 2020. During the quarter ended June 30, 2020 we recognized $108.8 million of impairments representing the difference between the assets' carrying value and the then estimated fair value of $192.8 million. The impaired assets, primarily senior housing communities, represent less than 1% of our consolidated net real estate property as of September 30, 2020. Impairments are recorded within depreciation and amortization in our Consolidated Statements of Income and are primarily related to our senior living operations reportable business segment.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Loss on financial instruments and impairment of unconsolidated entities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of September 30, 2020, we concluded that credit losses exist within certain of our non-mortgage loans receivables and government-sponsored pooled loan investments. As a result, we recognized credit loss charges of $5.0 million and $34.7 million for the three and nine months ended September 30, 2020. No allowances are recorded within our portfolios of secured mortgage loans or marketable debt securities. In addition, during the quarter ended June 30, 2020 we recognized an impairment of $10.7 million in an equity investment in an unconsolidated entity. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Deferred tax asset valuation allowance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of June 30, 2020, we concluded that it was not more likely than not that deferred tax assets (primarily US federal NOL carryforwards which begin to expire in 2032) would be realized based on our cumulative loss in recent years for certain of our taxable REIT subsidiaries. As a result, we recorded a valuation allowance of $56.4 million against these deferred tax assets on our Consolidated Balance Sheets with a corresponding charge to income tax benefit (expense) in our Consolidated Statements of Income for the quarter ended June 30, 2020. We maintained our conclusions regarding the realizability of deferred tax assets as of September 30, 2020.</span></div>
CY2020Q3	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	1200	property
CY2020Q3	vtr	Concentration Risk Numberof Tenants ConcentrationRiskNumberofTenants	3	tenant
CY2020Q3	vtr	Unit Conversion Factor For Common Stock UnitConversionFactorForCommonStock	0.9051
CY2020Q3	us-gaap	Redeemable Noncontrolling Interest Equity Other Fair Value RedeemableNoncontrollingInterestEquityOtherFairValue	129600000	USD
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Other Fair Value RedeemableNoncontrollingInterestEquityOtherFairValue	171200000	USD
CY2020Q3	vtr	Deferred Rent Receivable DeferredRentReceivable	164200000	USD
CY2019Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	278800000	USD
CY2020Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	129500000	USD
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	22600000	USD
CY2020Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	15748000	USD
CY2020Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	1987000	USD
CY2019Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	85527000	USD
CY2019Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	5224000	USD
	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	100000	USD
CY2020Q3	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	892500000	USD
CY2019Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	1000000000.0	USD
CY2020Q3	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	892464000	USD
CY2020Q3	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost	909455000	USD
CY2020Q3	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue	824342000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	21358000	USD
CY2019Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecurities	1005696000	USD
CY2019Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Amortized Cost SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesAmortizedCost	974510000	USD
CY2019Q4	vtr	Secured Loans Unsecured Loans And Other Available For Sale Securities Fair Value SecuredLoansUnsecuredLoansAndOtherAvailableForSaleSecuritiesFairValue	1006889000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	31186000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	1050742000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1051161000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	943809000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	922668000	USD
CY2020Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1389041000	USD
	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y3M18D
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1472408000	USD
	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y2M12D
CY2020Q3	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	339200000	USD
	vtr	Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod	P14Y3M18D
CY2019Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	349357000	USD
	vtr	Finite Lived Intangible Liabilities Below Market Leases Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesBelowMarketLeasesRemainingWeightedAverageAmortizationPeriod	P14Y6M
CY2020Q3	vtr	Other Finite Lived Intangible Liabilities Gross OtherFiniteLivedIntangibleLiabilitiesGross	13498000	USD
CY2019Q4	vtr	Other Finite Lived Intangible Liabilities Gross OtherFiniteLivedIntangibleLiabilitiesGross	13498000	USD
CY2020Q3	vtr	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	208959000	USD
CY2019Q4	vtr	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	203834000	USD
CY2020Q3	vtr	Indefinite Lived Intangible Liabilities Purchase Options IndefiniteLivedIntangibleLiabilitiesPurchaseOptions	3568000	USD
CY2019Q4	vtr	Indefinite Lived Intangible Liabilities Purchase Options IndefiniteLivedIntangibleLiabilitiesPurchaseOptions	3568000	USD
CY2020Q3	vtr	Finiteand Indefinite Lived Intangible Liabilities Net FiniteandIndefiniteLivedIntangibleLiabilitiesNet	147307000	USD
	vtr	Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod	P14Y3M18D
CY2019Q4	vtr	Finiteand Indefinite Lived Intangible Liabilities Net FiniteandIndefiniteLivedIntangibleLiabilitiesNet	162589000	USD
	vtr	Finite Lived Intangible Liabilities Remaining Weighted Average Amortization Period FiniteLivedIntangibleLiabilitiesRemainingWeightedAverageAmortizationPeriod	P14Y6M
CY2020Q3	vtr	Deferred Rent Receivable DeferredRentReceivable	164161000	USD
CY2019Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	278833000	USD
CY2020Q3	vtr	Nonmortgageloansreceivablenet Nonmortgageloansreceivablenet	56844000	USD
CY2019Q4	vtr	Nonmortgageloansreceivablenet Nonmortgageloansreceivablenet	63724000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	231168000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	237360000	USD
CY2020Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	4748000	USD
CY2019Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5149000	USD
CY2020Q3	vtr	Investmentin Unconsolidated Operating Entities InvestmentinUnconsolidatedOperatingEntities	43116000	USD
CY2019Q4	vtr	Investmentin Unconsolidated Operating Entities InvestmentinUnconsolidatedOperatingEntities	59301000	USD
CY2020Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	252498000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	233349000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	779475000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	877716000	USD
CY2020Q3	us-gaap	Commercial Paper CommercialPaper	0	USD
CY2019Q4	us-gaap	Commercial Paper CommercialPaper	567450000	USD
CY2020Q3	vtr	Longtermdebtandshorttermborrowingsgross Longtermdebtandshorttermborrowingsgross	12140667000	USD
CY2019Q4	vtr	Longtermdebtandshorttermborrowingsgross Longtermdebtandshorttermborrowingsgross	12245802000	USD
CY2020Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	73444000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	79939000	USD
CY2020Q3	vtr	Debt Instrument Unamortized Fair Value Adjustment DebtInstrumentUnamortizedFairValueAdjustment	14008000	USD
CY2019Q4	vtr	Debt Instrument Unamortized Fair Value Adjustment DebtInstrumentUnamortizedFairValueAdjustment	20056000	USD
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	33312000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27146000	USD
CY2020Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	12047919000	USD
CY2019Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	12158773000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	143721000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	510774000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1328970000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1616623000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1577210000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	6963369000	USD
CY2020Q3	vtr	Longtermdebtandshorttermborrowingsgross Longtermdebtandshorttermborrowingsgross	12140667000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600000000	USD
CY2020Q3	vtr	Commercialpaperprogramcapacity Commercialpaperprogramcapacity	1000000000.0	USD
CY2020Q3	us-gaap	Commercial Paper CommercialPaper	0	USD
CY2020Q3	vtr	Longtermdebtandshorttermborrowingsgross Longtermdebtandshorttermborrowingsgross	12140667000	USD
CY2019Q4	vtr	Longtermdebtandshorttermborrowingsgross Longtermdebtandshorttermborrowingsgross	12245802000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3200000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-95900000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-57000000.0	USD
CY2020Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	152900000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	53700000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	200800000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	300000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	47500000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	86918000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-54966000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-51743000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	17552000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	27380000	USD
CY2020Q3	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	-27628000	USD
CY2019Q4	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	-10201000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-65042000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-34564000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	13737000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	329232000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	426404000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	13737000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	86918000	USD
	us-gaap	Profit Loss ProfitLoss	329232000	USD
	us-gaap	Profit Loss ProfitLoss	426404000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	986000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1659000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	534000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4831000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12751000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	85259000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	328698000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	421573000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	373177000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	372426000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	372997000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	363724000	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	640000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	445000	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	163000	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	567000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	147000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	492000	shares
CY2020Q3	us-gaap	Profit Loss ProfitLoss	13737000	USD
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2955000	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2992000	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2968000	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	2996000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	376295000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	376625000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	376112000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	367657000	shares
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.88
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.17
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.04
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.23
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.88
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.16
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	vtr	Intersegmentsalesandtransfers Intersegmentsalesandtransfers	0	USD
CY2020Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	354512000	USD
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18666000	USD
CY2020Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	572000	USD
CY2020Q3	us-gaap	Revenues Revenues	918940000	USD
CY2020Q3	us-gaap	Revenues Revenues	918940000	USD
CY2020Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	572000	USD
CY2020Q3	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	494985000	USD
CY2020Q3	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	557000	USD
CY2020Q3	vtr	Netoperatingincome Netoperatingincome	422826000	USD
CY2020Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	572000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	115505000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	249366000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34228000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7386000	USD
CY2020Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11325000	USD
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	4999000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3534000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	865000	USD
CY2020Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	12622000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3195000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	13737000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	986000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12751000	USD
CY2019Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	408322000	USD
CY2019Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	30164000	USD
CY2019Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	620000	USD
CY2019Q3	us-gaap	Revenues Revenues	983155000	USD
CY2019Q3	us-gaap	Revenues Revenues	983155000	USD
CY2019Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	620000	USD
CY2019Q3	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	461493000	USD
CY2019Q3	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	627000	USD
CY2019Q3	vtr	Netoperatingincome Netoperatingincome	520415000	USD
CY2019Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	620000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	113967000	USD
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	234603000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40530000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-37434000	USD
CY2019Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4304000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2164000	USD
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	854000	USD
CY2019Q3	vtr	Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree IncomeLossFromEquityMethodInvestmentsAndRemeasurementGainOnEquityInterestInAcquiree	854000	USD
CY2019Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	36000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2005000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	86918000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	86918000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1659000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	85259000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1126934000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	62203000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	6965000	USD
	us-gaap	Revenues Revenues	2874192000	USD
	us-gaap	Revenues Revenues	2874192000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	6965000	USD
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	1474558000	USD
	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	1827000	USD
	vtr	Netoperatingincome Netoperatingincome	1390842000	USD
	us-gaap	Interest Expense InterestExpense	355333000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	847797000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106747000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7386000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	26129000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	34654000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10624000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-15861000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	240101000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	240101000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-95855000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	329232000	USD
	us-gaap	Profit Loss ProfitLoss	329232000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	534000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	328698000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1208388000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	66819000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	10109000	USD
	us-gaap	Revenues Revenues	2876746000	USD
	us-gaap	Revenues Revenues	2876746000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	10109000	USD
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	1327898000	USD
	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	1775000	USD
	vtr	Netoperatingincome Netoperatingincome	1536964000	USD
	us-gaap	Interest Expense InterestExpense	334955000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	696710000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	124369000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-41861000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11084000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9294000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2621000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	24633000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-57004000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	426404000	USD
	us-gaap	Profit Loss ProfitLoss	426404000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4831000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	421573000	USD
CY2020Q3	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	170613000	USD
CY2019Q3	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	888791000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	481999000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1269437000	USD
CY2020Q3	us-gaap	Revenues Revenues	918940000	USD
CY2019Q3	us-gaap	Revenues Revenues	983155000	USD
	us-gaap	Revenues Revenues	2874192000	USD
	us-gaap	Revenues Revenues	2876746000	USD
CY2020Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	20978412000	USD
CY2019Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	21734573000	USD

Files In Submission

Name	View Source	Status
0000740260-20-000163-index-headers.html	Edgar Link	pending
0000740260-20-000163-index.html	Edgar Link	pending
0000740260-20-000163.txt	Edgar Link	pending
0000740260-20-000163-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vtr-20200930.htm	Edgar Link	pending
vtr-20200930.xsd	Edgar Link	pending
vtr-20200930_cal.xml	Edgar Link	unprocessable
vtr-20200930_def.xml	Edgar Link	unprocessable
vtr-20200930_htm.xml	Edgar Link	completed
vtr-20200930_lab.xml	Edgar Link	unprocessable
vtr-20200930_pre.xml	Edgar Link	unprocessable
vtr-ex22_093020.htm	Edgar Link	pending
vtr-ex311_093020.htm	Edgar Link	pending
vtr-ex312_093020.htm	Edgar Link	pending
vtr-ex321_093020.htm	Edgar Link	pending
vtr-ex322_093020.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VTR
Ventas, Inc. Stock $vtr

2020 Q4 Form 10-Q Financial Statement

#000074026020000163 Filed on November 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VTR Ventas, Inc. Stock $vtr

2020 Q4 Form 10-Q Financial Statement

#000074026020000163 Filed on November 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VTR
Ventas, Inc. Stock $vtr